Hotline: 1800 102 2007
X
Search Business Opportunities
Business Growth 2014-09-24

Himalaya Drug aims at 12% revenue growth in FY15

Herbal wellness major Himalaya Drug Company is targeting about 12 per cent growth in revenue to Rs 1,450 crore this fiscal on robust sales in the domestic market.

By
Himalaya Drug aims at 12% revenue growth in FY15

Herbal wellness major Himalaya Drug Company is targeting about 12 per cent growth in revenue to Rs 1,450 crore this fiscal on robust sales in the domestic market, according to a PTI report.

The company that sells medicinal products, including the popular liver protective brand Liv.52, had posted revenues of Rs 1,300 crore in the previous fiscal.

"We are looking at clocking Rs 1,450 crore in revenues in the current fiscal year. Our revenue growth is primarily driven by growth in the domestic market," The Himalaya Drug Company CEO Philipe Haydon told PTI.

On the road map being planned by the company for future growth, Haydon said: "We are constantly exploring new routes to penetrate our brand across new categories, existing markets, new markets and multiple demographics."

The ayurvedic major is focusing on organic route for expansion and is undertaking research and development activities to develop new drugs.

"Our research pipeline is robust. We are in the advanced stage of drug development for cancer. We are also strengthening our presence in the nutraceutical segment," Haydon said.

When asked about the contribution of various segments for the overall revenues of the firm, Haydon said: "Currently pharmaceuticals and personal care contribute 38 per cent each. The remaining is contributed by baby care and animal health."

Contribution from exports, that is sale of Himalaya products to the companies subsidiaries overseas is at 12 per cent of the total revenue, he added.

The company has challenged the Delhi Medical Council (DMC) notification which says that doctors of modern medicine should not prescribe Ayurveda drugs.

"We have challenged the Delhi Medical Council (DMC) notification...The notification has wrongfully interpreted Section 30 of the Delhi Bhartiya Chikitsa Parishad Act, 1998... The government needs to clearly define the ambit of herbal drugs and non-prescription products used by the general public," Haydon said.

Comment
Related opportunities
  • Beauty Salons
    Studio99 – Unisex Salons & Spa A journey from Coffee Shop..
    Locations looking for expansion Delhi
    Establishment year 2018
    Franchising Launch Date 2018
    Investment size Rs. 10lac - 20lac
    Space required 300
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Delhi Delhi
  • HR & Recruitment
    Coppergate - a specialist headhunting, Staffing & Education Company looking..
    Locations looking for expansion Maharashtra
    Establishment year 2007
    Franchising Launch Date 2008
    Investment size Rs. 50 K - 2lac
    Space required 01
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquater Mumbai City Maharashtra
  • Computer Hardware & IT
    About Us: Mindlogicx is a global knowledge engineering company , and..
    Locations looking for expansion Karnataka
    Establishment year 2002
    Franchising Launch Date 2018
    Investment size Rs. 10lac - 20lac
    Space required -NA-
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater Bangalore Karnataka
  • Electric Vehicles (E-Vehicles)
    About Us: Chairman of our Group, Mr. JR Gupta founded ACT..
    Locations looking for expansion Punjab
    Establishment year 2018
    Franchising Launch Date 2018
    Investment size Rs. 5lac - 10lac
    Space required 400
    Franchise Outlets -NA-
    Franchise Type Unit, Multiunit
    Headquater Ludhiana Punjab
Insta-Subscribe to
The Franchising World
Magazine
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities
More Stories

Free Advice - Ask Our Experts